Day: October 30, 2023

Roll Out of Anshin Data Box Powered by Synchronoss Personal Cloud Integrates Artificial Intelligence Functionality and Enables Customers to Optimize, Organize, and Safeguard Photos, Videos, and Other Digital Content

BRIDGEWATER, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging, and digital products and platforms, today announced that SoftBank Corp. (“SoftBank”), one of Japan’s largest telecommunication carriers, has deployed Synchronoss Personal Cloud to power its Anshin Data Box service.

Anshin Data Box allows customers to backup and restore photos, videos, and files stored on mobile phones and other devices. Additionally, the platform’s artificial intelligence features provide the capability to optimize low resolution photos and create new types of content through a series of effects and stylizers.

Available in November across multiple distribution channels, SoftBank’s Anshin Data Box will include 500 gigabytes of storage per month. Additionally, the personal cloud service will be integrated into new devices, allowing customers to easily activate it during the onboarding process. SoftBank will also deliver Anshin Data Box through its retail stores and digital buy flow.

“We continue to empower telecom operators and mobile service providers with strategic tools to improve customer value,” said Jeff Miller, President and CEO of Synchronoss. “This new Cloud launch with SoftBank further extends our long-standing relationship with them and our presence in Japan. It also reinforces our cloud-first strategy, which represents new growth opportunities for the Synchronoss Personal Cloud platform.”

About Synchronoss
Synchronoss Technologies (Nasdaq: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding, and engage subscribers to unleash new revenue streams, reduce costs, and increase speed to market. Hundreds of millions of subscribers trust Synchronoss products to stay in sync with the people, services, and content they love. Learn more at www.synchronoss.com.

Media Relations Contact:
Domenick Cilea
Springboard
[email protected]

Investor Relations Contact:
Matt Glover and Tom Colton
Gateway Group, Inc.
[email protected]

GlobeNewswire Distribution ID 8968023

RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — In a groundbreaking development for the Middle East, King Faisal Specialist Hospital and Research Centre (KFSH&RC) has introduced a service called Rapid Whole-Genome Sequencing (rWGS) as part of its healthcare solutions. This service is designed to help doctors diagnose rare and genetic disorders, particularly in critically ill newborns, who require fast and precise identification of their conditions.

The Rapid Whole Genome Sequencing service is invaluable for newborns with rare diseases, as it helps them avoid the often lengthy process of tests and treatments that can stretch for months or even years without a precise diagnosis. This increases the chances of survival and reduces the overall healthcare cost by minimizing hospital admissions, unnecessary tests, and medical care.

KFSH&RC Rapid Whole Genome Sequencing _ 02

Remarkably, the hospital has reduced the time required for this genetic testing from the typical two-month duration to less than 35 hours. Response time is paramount when planning healthcare for critically ill newborns, and swift delivery of test results ensures a prompt and tailored medical response, preventing delays that could otherwise lead to worsening the patient’s condition or even death.

As part of its participation in the Global Health Summit, where KFSH&RC plays a vital role as a strategic healthcare partner, the hospital shares details about the Rapid Whole Genome Sequencing service at its exhibition booth. The hospital’s cutting-edge capabilities include analyzing up to 99% of DNA sequences from patient blood samples, along with several innovative healthcare solutions.

The comprehensive genetic composition examination involves a streamlined four-step process. First, the DNA is broken down into manageable segments. Then, it is encoded with a barcode-like symbol for easy identification, similar to tracking products in a store. The examination itself is conducted using specialized equipment. Finally, advanced computer systems and software compare these sequences, identifying differences in DNA sequences and pinpointing the genetic mutations responsible for diseases.

KFSH&RC provides the highest level of healthcare and offers the best possible patient experience within an integrated educational and research environment. It collaborates and shares expertise with leading local, regional, and international institutions to provide a globally competitive service in clinical, research, and educational fields.

Globally renowned for its specialized healthcare, KFSH&RC is a pioneer in medical innovation and a hub for advanced medical research and education. It is committed to advancing medical technologies and raising the standard of healthcare worldwide through partnerships with top local, regional, and international institutions in clinical, research, and educational sectors.

Contact information:
[email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/59bc8aa4-5f6d-432a-b4e9-c26544e9aa6d

https://www.globenewswire.com/NewsRoom/AttachmentNg/76f80d26-8e56-42df-b95a-c8cdab80e449

GlobeNewswire Distribution ID 8968201

RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — In a groundbreaking development for the Middle East, King Faisal Specialist Hospital and Research Centre (KFSH&RC) has introduced a service called Rapid Whole-Genome Sequencing (rWGS) as part of its healthcare solutions. This service is designed to help doctors diagnose rare and genetic disorders, particularly in critically ill newborns, who require fast and precise identification of their conditions.

The Rapid Whole Genome Sequencing service is invaluable for newborns with rare diseases, as it helps them avoid the often lengthy process of tests and treatments that can stretch for months or even years without a precise diagnosis. This increases the chances of survival and reduces the overall healthcare cost by minimizing hospital admissions, unnecessary tests, and medical care.

KFSH&RC Rapid Whole Genome Sequencing _ 02

Remarkably, the hospital has reduced the time required for this genetic testing from the typical two-month duration to less than 35 hours. Response time is paramount when planning healthcare for critically ill newborns, and swift delivery of test results ensures a prompt and tailored medical response, preventing delays that could otherwise lead to worsening the patient’s condition or even death.

As part of its participation in the Global Health Summit, where KFSH&RC plays a vital role as a strategic healthcare partner, the hospital shares details about the Rapid Whole Genome Sequencing service at its exhibition booth. The hospital’s cutting-edge capabilities include analyzing up to 99% of DNA sequences from patient blood samples, along with several innovative healthcare solutions.

The comprehensive genetic composition examination involves a streamlined four-step process. First, the DNA is broken down into manageable segments. Then, it is encoded with a barcode-like symbol for easy identification, similar to tracking products in a store. The examination itself is conducted using specialized equipment. Finally, advanced computer systems and software compare these sequences, identifying differences in DNA sequences and pinpointing the genetic mutations responsible for diseases.

KFSH&RC provides the highest level of healthcare and offers the best possible patient experience within an integrated educational and research environment. It collaborates and shares expertise with leading local, regional, and international institutions to provide a globally competitive service in clinical, research, and educational fields.

Globally renowned for its specialized healthcare, KFSH&RC is a pioneer in medical innovation and a hub for advanced medical research and education. It is committed to advancing medical technologies and raising the standard of healthcare worldwide through partnerships with top local, regional, and international institutions in clinical, research, and educational sectors.

Contact information:
[email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/59bc8aa4-5f6d-432a-b4e9-c26544e9aa6d

https://www.globenewswire.com/NewsRoom/AttachmentNg/76f80d26-8e56-42df-b95a-c8cdab80e449

GlobeNewswire Distribution ID 8968201

RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — In a groundbreaking development for the Middle East, King Faisal Specialist Hospital and Research Centre (KFSH&RC) has introduced a service called Rapid Whole-Genome Sequencing (rWGS) as part of its healthcare solutions. This service is designed to help doctors diagnose rare and genetic disorders, particularly in critically ill newborns, who require fast and precise identification of their conditions.

The Rapid Whole Genome Sequencing service is invaluable for newborns with rare diseases, as it helps them avoid the often lengthy process of tests and treatments that can stretch for months or even years without a precise diagnosis. This increases the chances of survival and reduces the overall healthcare cost by minimizing hospital admissions, unnecessary tests, and medical care.

KFSH&RC Rapid Whole Genome Sequencing _ 02

Remarkably, the hospital has reduced the time required for this genetic testing from the typical two-month duration to less than 35 hours. Response time is paramount when planning healthcare for critically ill newborns, and swift delivery of test results ensures a prompt and tailored medical response, preventing delays that could otherwise lead to worsening the patient’s condition or even death.

As part of its participation in the Global Health Summit, where KFSH&RC plays a vital role as a strategic healthcare partner, the hospital shares details about the Rapid Whole Genome Sequencing service at its exhibition booth. The hospital’s cutting-edge capabilities include analyzing up to 99% of DNA sequences from patient blood samples, along with several innovative healthcare solutions.

The comprehensive genetic composition examination involves a streamlined four-step process. First, the DNA is broken down into manageable segments. Then, it is encoded with a barcode-like symbol for easy identification, similar to tracking products in a store. The examination itself is conducted using specialized equipment. Finally, advanced computer systems and software compare these sequences, identifying differences in DNA sequences and pinpointing the genetic mutations responsible for diseases.

KFSH&RC provides the highest level of healthcare and offers the best possible patient experience within an integrated educational and research environment. It collaborates and shares expertise with leading local, regional, and international institutions to provide a globally competitive service in clinical, research, and educational fields.

Globally renowned for its specialized healthcare, KFSH&RC is a pioneer in medical innovation and a hub for advanced medical research and education. It is committed to advancing medical technologies and raising the standard of healthcare worldwide through partnerships with top local, regional, and international institutions in clinical, research, and educational sectors.

Contact information:
[email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/59bc8aa4-5f6d-432a-b4e9-c26544e9aa6d

https://www.globenewswire.com/NewsRoom/AttachmentNg/76f80d26-8e56-42df-b95a-c8cdab80e449

GlobeNewswire Distribution ID 8968201

Bed waiting time reduced from 32 hours to 6 hours

RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — Healthcare providers are facing a continuous increase in the demand for healthcare services, necessitating a redirection of efforts towards improving the operational efficiency of healthcare institutions. In response to this challenge that healthcare providers worldwide face, the Capacity Command Center in King Faisal Specialist Hospital and Research Centre (KFSH&RC) has emerged as a pioneer in enhancing operational efficiency by implementing globally recognized procedures. It essentially aims to improve overall healthcare outcomes in alignment with the goals of Saudi Vision 2030.

Since its launch in September 2021, the Center has executed over 170,000 intervention procedures, significantly reducing bed waiting times from 32 hours to 6 hours. The emergency department has also seen a 14% reduction in waiting times. Furthermore, waiting times in the pharmacy and laboratory have improved, with over 90% of beneficiaries receiving services in less than 15 minutes.

Since its establishment, the Center has become the primary source for data-driven decision-making, it continuously monitors patient movements to maintain care quality, adhere to standard operating procedures, and predict demand volumes to mitigate risks and address potential challenges.

KFSH&RC’s Capacity Command Center is a Pioneering Model for Achieving Maximum Operational Efficiency_01

Simultaneously, as a strategic health partner at the Global Health Exhibition in Riyadh from October 29-31, KFSH&RC showcases its mechanisms for improving operational efficiency, healthcare outcomes, and the patient experience, positioning itself as a leading healthcare solution in the region.

The Capacity Command Center relies on a strategy that adjusts business plans and interventions based on evidence-based practices driven by artificial intelligence to improve workflow mapping and planning. The Center’s services include technical reporting, data mining, operational performance enhancement, and review processes and plans, culminating in regular report issuance.

This Center is part of KFSH&RC’s ongoing efforts to harness all resources and bring the latest technologies to improve outcomes and operational efficiency. It aims to be the optimal choice for every patient seeking specialized healthcare services, making these services accessible to a broader range of beneficiaries.

KFSH&RC is globally renowned for providing specialized healthcare and is a pioneer in innovation, advanced medical research, and medical education. The institution actively seeks to develop medical technologies and enhance the standard of healthcare worldwide, collaborating with leading local, regional, and international organizations to deliver world-class services in clinical, research, and educational domains.

Contact information:
[email protected]

Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fe240c06-779b-48f8-bf90-542602be547f

https://www.globenewswire.com/NewsRoom/AttachmentNg/879c9435-ea23-47f2-b81a-240a1e2bb3a5

GlobeNewswire Distribution ID 8968149